Quarterly Result12 Aug 2026, 06:41 pm
Bal Pharma Ltd Files Q1 FY27 Unaudited Financial Results
AI Summary
Bal Pharma Ltd has submitted its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The results were approved by the Board of Directors during a meeting held on August 12, 2026. The company also confirmed that no funds were raised through public or preferential issues during the quarter, making the filing of a statement of deviation/variation in utilization of funds not applicable. The statutory auditors, M/s. SSJNB & Co, have issued an unmodified opinion on the financial results.
Key Highlights
- Unaudited financial results for Q1 FY27 filed.
- Board of Directors approved the financial statements.
- Statutory auditors issued an unmodified review report.
- No fund raising activities, so deviation statement not applicable.
- Results prepared as per Ind AS 34 and SEBI regulations.
Price Impact
More from BALPHARMA